Abstract
The morphological organization of central monoamine systems has suggested a functional linkage of noradrenergic and serotonergic neurons ever since Dahlstrom and Fuxe (1964) demonstrated, by means of a sensitive fluorescence method, the neuronal localization of norepinephrine (NE) and serotonin (5HT) and mapped NE and 5HT containing cell bodies and terminals in the central nervous system. These and more recent studies show that NE and 5HT neurons form monosynaptic pathways between the lower brain stem and the cerebral cortex (Dahlstrom and Fuxe, 1964; Anden et al., 1966; Moore and Bloom, 1979; Levitt and Moore, 1978; Morrison et al., 1982; Consolazione and Cuello, 1982). With the introduction of immunohistochemical techniques, it became evident that NE and 5HT containing neurons project to the entire neuraxis and, within the cerebral cortex, to all six cortical layers, though some topographical and species differences exist (Lindvall and Bjorklund, 1984; Levitt et al., 1984). Early work also indicated a high degree of catecholamine innervation of 5HT cell bodies in the raphe nuclei (Dahlstrom and Fuxe, 1964) and the existence of a 5HT innervation of NE cell bodies in the locus coeruleus (Pickel et al., 1975). The details of the monoaminergic pathways in the central nervous system have been authoritatively reviewed (Jacobowitz, 1978; Moore and Bloom, 1979; Consolazione and Cuello, 1982). As pointed out by Fuxe et al. (1978), there is little doubt that the 5HT and NE neurons are linked together neuroanatomically and that they influence one another at various points on the neural axis.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Affolter, H., Erne, P., Burgisser, E. and Pletscher, A., Ca++ as a messenger of 5HT receptor stimulation in human blood platelets, Naunyn-Schmiede-berg’s 2 Arch. Pharmacol, 325: 337–342 (1984).
Anden, N. E., Dahlstrom, A., Fuxe, K., Larsson, K., Olson, L. and Ungerstedt, U., Ascending monoamine neurons to the telencephanon and diencephalon, Acta physiol. Scand. 67: 313–326 (1966).
Barbaccia, M. L., Brunello, N., Chuang, D. M. and Costa, E., On the mode of action of imipramine: Relationship between serotonergic axon terminal function and down-regulation of beta adrenergic receptors, Neuropharmacology 22: 373–383 (1983).
Berridge, M. J., Rapid accumulation of inositol triphosphate reveals that agonists hydrolyse polyphosphoinositides instead of phosphatidylinositol, Biochem. J. 212: 849–858 (1983).
Berridge, M. J., Inositol trisphosphate and diacylglycerol as second messengers, Biochem. J., 220: 345–360 (1984).
Berridge, M. J., Dawson, C., Downes, C. P., Heslop, J. P. and Irvine, R. K., Changes in the levels of inositol phosphates after agonist-dependent hydrolysis of membrane phosphoinositides, Biochem. J. 212: 473–482 (1983).
Berridge, M. J., Downes, P. C. and Hanely, M. R., Lithium amplifies agonistdependent phosphatidylinositol responses in brain and salivary glands, Biochem. J. 206: 587–595 (1982).
Brunello, N., Chuang, D. M., Costa, E., Use of specific brain lesions to study the site of action of antidepressants, Adv. Biosc. 40: 141–145 (1982).
Brunello, N., Volterra, A., Cagiano, R., Ianieri, G. C., Cuomo, V. and Racagni, G., Biochemical and behavioral changes in rats after prolonged treatment with desipramine: Interaction with p-chlorophenylalanine, Naunyn-Schmiedeberg’s Arch. Pharmacol. 331: 20–22 (1985).
Conn, P. J. and Sanders-Bush, E., Selective 5HT2 antagonists inhibit serotonin stimulated phosphatidylinositol metabolism in cerebral cortex, Neuropharmacology 23: 993–996 (1984).
Conn, P. J. and Sanders-Bush, E., Serotonin-stimulated phosphoinositide turnover: mediation by the S2 binding site in rat cerebral cortex but not in subcortical regions, J. Pharmacol. Exp. Ther. 234: 195–203 (1985).
Conn, P. J. and Sanders-Bush, E., Regulation of serotonin stimulated phosphoinositide hydrolysis: Relation to the serotonin 5HT2 binding site, J. Neurosci. (submitted) (1986a).
Conn, P. J. and Sanders-Bush, E., Agonist induced phosphoinositide hydrolysis in rat choroid plexus, J. Neurochem. (submitted) (1986b).
Conn, P. J., Sanders-Bush, E., Hoffman, B. J. and Hartig, P. R., A unique serotonin receptor in choroid plexus is linked to phosphoinositide hydrolysis, Proc. Natl. Acad. Sci., in press (1986).
Consolazione, A. and Cuello, A. C., CNS serotonin pathways, In: Biology of serotonergic transmission, N. N. Osborne, ed., pp. 29–61, John Wiley and Sons, Ltd., Baffius Lane, England (1982).
Coppen, A. and Wood, K., 5-Hydroxytryptamine in the pathogenesis of affective disorders, Adv. Biochem. Psychopharmacol. 34: 249–258 (1982).
Crook, R. B., Farber, M. B. and Prusiner, S. B., Hormone and neurotransmitters control cyclic AMP metabolism in choroid plexus epithelial cells, J. Neurochem. 42: 340–350 (1984).
Dahlstrom, A. and Fuxe, K., Evidence for the existence of monoamine-containing neurons in the central nervous system I. Demonstration of monoamines in the cell bodies of brain stem neurons, Acta. Physiol. Scand. 62 (Suppl. 232): 1–55 (1964).
de Chaffoy de Courcelles, D., Roevens, P. and Van Belle, H., Stimulation by serotonin of 40 KDa and 20 KDa protein phosphorylation in human platelets, FEBS Lett. 171: 289–292 (1984).
de Chaffoy de Courcelles, D., Leysen, J. E., de Clerck, F., Van Belle, H. and Janssen, P. A. J., Evidence that phospholipid turnover is the signal transducing system coupled to serotonin-S2 receptor sites, J. Biol. Chem. 260: 7603–7608 (1985).
Dumbrille-Ross, A. and Tang, S. W., Noradrenergic and serotonergic input necessary for imipramine induced changes in beta but not S2 receptor densities, Psychiatry Res. 9: 207–215 (1983).
Fuxe, K., Hokfelt, T., Agnati, L. F., Johansson, O., Goldstein, M., Perez de la Mora, M., Possami, L., Tapia, R., Teran, L. and Palacios, R., Mapping out central catecholamine neurons: Immunohistochemical studies on catecholamine-synthesizing enzymes. In: Psychopharmacology: A generation of progress, M. A. Lipton, A. DiMascio, K. K. Killam, eds. pp. 67–94, Raven Press, NY, NY (1978).
Gilbert, R. F. T., Bennett, G. W., Marsden, C. A. and Emson, P. C., The effects of 5-hydroxytryptamine depleting drugs on peptides in the ventral spinal cord, Europ. J. Pharmacol. 76: 203–210 (1981).
Harden, T. K., Agonist-induced desensitization of the beta adrenergic receptor-linked adenylate cyclase. Pharmacol. Rev. 35: 5–32 (1983).
Hegstrand, L. R., Minneman, K. P. and Molinoff, P. B., Multiple effects of guanosine triphosphate on beta adrenergic receptors and adenylate cyclase activity in rat heart, lung and brain, J. Pharmacol. Exp. Ther. 210: 215–221 (1979).
Hirasawa, K. and Nishizuka, Y., Phosphatidylinositol turnover in receptor mechanisms and signal transduction, Ann. Rev. Pharmacol. Toxicol. 25: 147–170 (1985).
Hirata, F. and Axelrod, J., Phospholipid methylation and the transmission of biological signals through membranes, Science 209: 1082–1090 (1980).
Jacobowitz, D. M., Monoaminergic pathways in the central nervous system, In: Psychopharmacology: A generation of progress, M. A. Lipton, A. DiMascio, K. K. Killam, eds., pp. 119–129, Raven Press, New York, NY (1978).
Janowsky, A., Okada, F., Manier, D., Applegate, C. D. and Sulser, F., Role of serotonergic input in the regulation of the beta-adrenergic receptorcoupled adenylate cyclase system, Science 218: 900–901 (1982).
Kendall, D. A. and Nahorski, S. R., 5-hydroxytryptamme stimulated inositol phospholipid hydrolysis in rat cerebral cortex slices: Pharmacological characterization and effects of antidepressants, J. Pharmaco. Exper. Therap. 233: 473–479 (1985).
Levitt, P. and Moore, R. Y., Noradrenaline neuron innervation of the neurocortex in the rat, Brain Res. 139: 219–232 (1978).
Levitt, P., Rakic, P. and Goldman-Rakic, P. S., Comparative assessment of monoamine afferents in mammalian cerebral cortex, Neurology and Neurobiology 10: 41–59 (1984).
Lindvall, O. and Bjorkluna, A., General organization of cortical monoamine systems, Neurology and Neurobiology 10: 9–40 (1984).
Maeda, K., Monoaminergic effect on cerebrospinal fluid production, Nihon Univ. J. Med. 25: 155–174 (1983).
Manier, D. H., Gillespie, D. D., Steranka, L. R. and Sulser, F., A pivotal role for serotonin in the down-regulation of beta-adrenoceptors by antidepressants: Reversibility of the action of p-chlorophenylaianine (PCPA) by 5-hydroxytryptophan, Experientia 40: 1223–1226 (1984).
Manier, D. H., Gillespie, D. D., Sanders-Bush, E. and Sulser, F., The serotonin/noradrenaline-link in brain: I. The role of noradrenaline and serotonin in tne regulation of density and function of beta adrenoceptors and its alteration by DMI, Naunyn-Schmiedeberg’s Arch. Pharmacol. submitted (1986).
Mendlewicz, J. and Youdim, M. B. H., Antideprebsant potentiation of 5-hy-droxytryptophan by 1-deprenyl in affective illness, J. Affect. Disord. 2: 137–146 (1980).
Mobley, P. L., Manier, D. H. and Sulser, F., Norepinephrine-sensitive adenylate cyclase system in rat brain: Role of adrenal corticosteroids, J. Pharmacol. Exp. Ther. 226: 71–77 (1983).
Moore, R. Y., Bloom, F. E., Central catecholamine neuron systems: Anatomy and physiology of the norepinephrine and epinephrine systems, Ann. Rev. Neurosci. 2: 113–168 (1979).
Morrison, J. H., Foote, S. L., Molliver M. E., Bloom, F. E. and Lidov, H. G. W., Noradrenergic and serotonergic fibers innervate complementary layers in monkey primary visual cortex: An immunohistochemical study, Proc. Natl. Acad. Sci. USA 79: 2401–2405 (1982).
Nathanson, J., Beta-adrenergic sensitive adenylate cyclase in secretory cells of choroid plexus, Science 204: 843–844 (1979).
Nestler, E. J. and Greengard, P., Protein phosphorylation in brain. Nature 305: 583–588 (1983).
Nestler, E. J., Walaas, S. T. and Greengard, P., Neuronal phosproteins: Physiological and clinicax implications, Science 225: 1557–1364 (1984).
Nimgaonkar, V. L., Goodwin, G. M., Davies, C. L. and Green, A. R., Downregulation of beta-adrenoceptors in rat cortex by repeated administration of desipramine, electroconvulsive shock and clembuterol requires 5HT neurones but not 5HT, Neuropharmacology 24: 279–285 (1985).
O’Donnell, J. M. and Frazer, A., Effects of clenbuterol and tricyclic antidepressants on beta-adrenergic receptor/N-protein coupling in rat cerebral cortex, Fed. Proc. 43: 839 (1984).
Okada, F., Tokumitsu, Y. and Ui, M., Desensitization of beta adrenergic receptor coupled adenylate cyclase in cerebral cortex after treatment in vivo of rats with desipramine, J. Neurochem. in press (1986).
Pazos, A., Hoyer, D. and Palacios, J. M., The binding of serotonergic ligand to the porcine choroid plexus: Characterization of a new type of serotonin recognition site, Europ. J. Pharmacol. 106: 539–546 (1984).
Pickel, V. M., Joh, T. H., Field, P. M., Becker, C. G. and Reis, D. J., Cellular localization of tyrosine hydroxylase by immunohistochemistry, J. Histochem. Cytochem. 23: 1–12 (1975).
Roth, B. L., Nakaki, T., Chuang, D. M., Chemow, B. and Costa, E., Characterization of 5HT2 receptors linked to phospholipase C in rat aorta, Fed. Proc. 44: 1244 (1985).
Roth, B. L., Nakaki, T., Chuang, D. M. and Costa, E., Aortic recognition sites for serotonin (5HT) are coupled to phospholipase C and modulate phosphatidylinositol turnover, Neuropharmacology 23: 1223–1225, (1984).
Shopsin, B., Friedman, E. and Gershon, S., The use of synthesis inhibitors in defining a role for biogenic amines during imipramine treatment in depressed patients, Psychopharmacol. Comm. 1: 239–249 (1975).
Shopsin, B., Friedman, E. and Gershon, S., Parachlorophenylalanine reversal of tranylcypromine effects in depressed patients, Arch. Gen. Psych. 33: 811–819 (1976).
Stockmeier, C. A., Martino, A. M. and Kellar, K. J., A strong influence of serotonin axons on beta-adrenergic receptors in rat brain, Science 230: 323–325 (1985).
Sulser, F., Noraderenergic receptor regulation and the action of antidepressants. In “Depression and Antidepressants — Recent Events, pp. 24–36, excerpta Medica, Amsterdam (1983).
Sulser, F., The serotonin-noradrenaline link-hypothesis of affective disorders, in: Psychiatry, vol. 2, Eds. P. Pichot, P. Berner, R. Wolf and K. Thau, Plenum Publishing Corporation, pp. 411–416 (1985).
Sulser, F., Conn, P. J., Zawad, J. S. and Sanders-Bush, E., Molecular aspects of altered transmembrane regulation of the noradrenaline signal by antidepressants, Benzon Symposium on Drug Action, Copenhagen, in press (1986).
Van Praag, H. M., Serotonin precursors in the treatment of depression, Adv. Biochem. Psychopharmacol. 34: 259–286 (1982).
Whybrow, P. and Mendels, J., Toward a biology of depression: Some suggestions from neurophysiology, Amer. J. Psychiatry 125: 45–54 (1969).
Yagaloff, K. A. and Hartig, P. R., [125T]-LSD binds to a novel serotonergic site on rat choroid plexus epithelial cells, J. Neurosci. 5: 3178–3183 (1985).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1987 Plenum Press, New York
About this chapter
Cite this chapter
Sulser, F., Sanders-Bush, E. (1987). The Serotonin-Norepinephrine Link Hypothesis of Affective Disorders: Receptor-Receptor Interactions in Brain. In: Ehrlich, Y.H., Lenox, R.H., Kornecki, E., Berry, W.O. (eds) Molecular Mechanisms of Neuronal Responsiveness. Advances in Experimental Medicine and Biology, vol 221. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-7618-7_35
Download citation
DOI: https://doi.org/10.1007/978-1-4684-7618-7_35
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4684-7620-0
Online ISBN: 978-1-4684-7618-7
eBook Packages: Springer Book Archive